BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9394741)

  • 1. NSAIDs to prevent colorectal cancer: a question of sensitivity.
    Elder DJ; Paraskeva C
    Gastroenterology; 1997 Dec; 113(6):1999-2003. PubMed ID: 9394741
    [No Abstract]   [Full Text] [Related]  

  • 2. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.
    Gupta RA; Dubois RN
    Nat Rev Cancer; 2001 Oct; 1(1):11-21. PubMed ID: 11900248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Specificity, action, indications and safety. Criteria for the use of COX-2 inhibitors].
    Wigand R
    Pharm Unserer Zeit; 2002; 31(2):190-8. PubMed ID: 11977455
    [No Abstract]   [Full Text] [Related]  

  • 4. [New anti-inflammatory analgetics--are they needed?].
    Paakkari I
    Duodecim; 1999; 115(20):2217-24. PubMed ID: 11973925
    [No Abstract]   [Full Text] [Related]  

  • 5. Aspirin and the prevention of colorectal cancer.
    Berman KS
    N Engl J Med; 2003 Jun; 348(24):2466-7; author reply 2466-7. PubMed ID: 12803217
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma].
    Tuynman JB; Hulscher JB; Steller EP; van Lanschot JJ; Richel DJ
    Ned Tijdschr Geneeskd; 2003 Nov; 147(45):2207-12. PubMed ID: 14640057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of non-steroidal anti inflammatory drugs (NSAIDs)--COX-2 inhibitors].
    Tishler M; Langevetiz P; Nesher G
    Harefuah; 2002 Oct; 141(10):920-1. PubMed ID: 12420601
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cyclooxygenase 2 inhibitors and adenomatous polyposis coli].
    Florent C; Meary N
    Bull Cancer; 2004 May; 91 Spec No():S85-8. PubMed ID: 15239335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COX-2 inhibition as a tool to treat and prevent colorectal cancer.
    Tuynman JB; Peppelenbosch MP; Richel DJ
    Crit Rev Oncol Hematol; 2004 Nov; 52(2):81-101. PubMed ID: 15501074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Colorectal cancer and inhibition of cyclooxygenase-2].
    Geissler M; Mohr L; Blum HE
    Dtsch Med Wochenschr; 2002 Jun; 127(23):1256-8. PubMed ID: 12053285
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of NSAIDs for the chemoprevention of colorectal cancer.
    Herendeen JM; Lindley C
    Ann Pharmacother; 2003 Nov; 37(11):1664-74. PubMed ID: 14565811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current post-marketing information. Effects and adverse effects of celecoxib].
    Schmidt H; Geisslinger G
    Pharm Unserer Zeit; 2002; 31(2):180-7. PubMed ID: 11977454
    [No Abstract]   [Full Text] [Related]  

  • 13. COX-1 and COX-2 inhibition: current status and future perspective.
    Greyn J; Lauwers MH; Vanlersberghe C; Camu F
    Acta Anaesthesiol Belg; 1998; 49(3):175-83. PubMed ID: 9844704
    [No Abstract]   [Full Text] [Related]  

  • 14. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
    Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
    In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II.
    Moyad MA
    Semin Urol Oncol; 2001 Nov; 19(4):306-16. PubMed ID: 11769882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COX-2-specific inhibition: implications for clinical practice.
    Pascucci RA
    J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S18-22. PubMed ID: 10643177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin use and potential mechanisms for colorectal cancer prevention.
    Williams CS; Smalley W; DuBois RN
    J Clin Invest; 1997 Sep; 100(6):1325-9. PubMed ID: 9294096
    [No Abstract]   [Full Text] [Related]  

  • 18. Getting a grip on pain. A new drug may revolutionize arthritis care.
    Cowley G
    Newsweek; 1998 Dec; 132(24):66. PubMed ID: 10338868
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevention of colorectal cancer: acetylsalicyclic acid and cyclo-oxygenase-2 inhibitors are only partially effective].
    Kleibeuker JH; de Vries EG
    Ned Tijdschr Geneeskd; 2003 Nov; 147(45):2203-7. PubMed ID: 14640056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2 inhibition prevents colorectal cancer: from the bench to the bed side.
    Samoha S; Arber N
    Oncology; 2005; 69 Suppl 1():33-7. PubMed ID: 16210875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.